According to Emergen Research, the global diabetic ketoacidosis market size was USD 1297.3 million in 2019 and is expected to reach USD 1973.6 million in 2027 and register a revenue CAGR of 6.2% during the forecast period, 2020-2027.
Emergen Research has published its latest report titled, “Diabetic Ketoacidosis Market Analysis, By Treatment Type (Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Intermediate-Acting Insulin, Long-Acting Insulin), By End Use (Hospitals, Ambulatory Care Center, Specialty Clinics), and By Region Forecasts To 2027”
According to Emergen Research, the global diabetic ketoacidosis market size was USD 1297.3 million in 2019 and is expected to reach USD 1973.6 million in 2027 and register a revenue CAGR of 6.2% during the forecast period, 2020-2027.
Market Dynamics:
Diabetic ketoacidosis is a life-threatening complication associated with diabetes that occurs when the body begins to break down fats instead of sugars, producing high levels of blood acids, ketones. Diabetic ketoacidosis is a serious complication of type 1 diabetes and is less commonly seen in type 2 diabetes. Type 1 diabetes, stomach illnesses, skipping insulin dose often, recent stroke, chronic illness or trauma, high usage of medicines like steroids and antipsychotics are some of the major risk factors that can lead to diabetic ketoacidosis.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/73
Over the recent years, there have been rapid advancements in diabetic ketoacidosis treatment. Many small to medium hospitals and healthcare centers are focusing on adopting latest treatment facilities owing to increasing healthcare expenditure and rising prevalence of type 1 diabetes globally. Factors such as increasing investments for developing novel drugs and therapies for diabetic ketoacidosis, increasing awareness about early diagnosis and treatment, and favorable reimbursement scenarios are expected to fuel market growth during the forecast period. In addition, government initiatives, increasing funds by private and public organizations, and increasing focus on developing effective long-acting insulin are expected to boost global market growth going ahead.
However, factors such as adverse side effects associated with diabetic ketoacidosis treatment, lack of awareness about diabetic ketoacidosis, and available treatment especially in the developing countries are expected to restrain overall market growth during the forecast period. In addition, dearth of skilled healthcare professionals, limited availability of advanced facilities in many hospitals and healthcare centers, and requirement of constant monitoring of insulin levels are expected to hamper overall market growth going ahead.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Insulin Therapy Segment to Register Significant Revenue Growth:
The insulin therapy segment is expected to register significant revenue growth over the forecast period. Factors such as increasing incidence of diabetes and diabetic ketoacidosis around the globe, high preference for insulin therapy due to its cost-effectiveness and high efficiency, and rapid advancements in insulin therapy are expected to drive revenue growth of the segment.
Buy Your Copy Now (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/73
Hospital Segment to Account for Largest Revenue Share:
The hospital segment is expected to account for largest revenue share over the forecast period owing to high prevalence of diabetes and risks of diabetic ketoacidosis across the globe, increasing patient admission in hospitals due to availability of advanced treatment facilities, and rising public awareness about treatment.
North America to Lead In Terms of Revenue:
North America is expected to dominate other regional markets in terms of revenue share over the forecast period. This can be attributed to factors such as rising prevalence of diabetes and associated complications such as diabetic ketoacidosis across the region, presence of well-developed healthcare infrastructure and research facilities, and availability of advanced treatment for diabetic ketoacidosis. Moreover, presence of key market players, high awareness about early diagnosis and treatment, and favorable reimbursement scenarios are expected to fuel North America market growth during the forecast period.
Major Companies in the Market Include:
- Biocon
- Merck
- Novo Nordisk
- Bristol-Myers Squibb
- AstraZeneca
- Sanofi
- Pfizer
- Eli Lilly and Company
- Tonghua Dongbao Pharmaceutical Co. Ltd.
- Wockhardt
- GlaxoSmithKline
- Oramed Pharmaceuticals
- Adocia
Click on the link to read key highlights of the report and look at projected trends for years to come: https://www.emergenresearch.com/industry-report/diabetic-ketoacidosis-market
For the purpose of this report, Reports and Data has segmented diabetic ketoacidosis market on the basis of treatment type, end use and region:
Treatment Type Outlook (Revenue in Million USD; 2017–2027)
- Fluid Replacement
- Electrolyte Replacement
- Insulin Therapy
- Intermediate-Acting Insulin
- Long-Acting Insulin
End Use Outlook (Revenue in Million USD; 2017–2027)
- Hospitals
- Ambulatory Care Centre
- Specialty Clinics
Regional Outlook (Revenue, USD Million; 2017–2027)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2030
Chapter 3. Key Insights
Chapter 4. Diabetic Ketoacidosis Market Segmentation & Impact Analysis
4.1. Diabetic Ketoacidosis Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.3. Market restraints analysis
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continued…
Explore Complete Table of Content@ https://www.emergenresearch.com/industry-report/diabetic-ketoacidosis-market/toc
Latest Published Reports by Emergen Research:
Mobile Phlebotomy Services Market By Services (Process & Handling, Specimen Collection, Specimen Shipping), By Application (Cancer, Biosimilar, Vaccine Clinical Trials), By End-Use (Doctors & Nurses, Individuals, Medical Laboratories, and Others), and By Region Forecast to 2028
Life and Pensions Business Processing Outsourcing (BPO) Market By Type, By Services, By Organization Size, By Buyer Type, and By Region Forecast to 2028
Food Delivery Services Market Size, Share, Trends, By Platform (Online, Offline, Online to Offline (O2O)), By Model (Platform to Customer, Aggregators, Full-Stack Model, Restaurant to Consumer Model), By Type, By Application, and By Region Forecast to 2028
Top Food Delivery Services Companies in the World
Top 10 Leading Companies In The Low-cost Satellites Market
Top 10 Leading Cloud TV Companies in The World
Top 10 Companies in the Drone Package Delivery Industry
World Top 10 Companies Offering Artificial Intelligence in BFSI
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Our Press Release@ https://www.emergenresearch.com/press-release/global-diabetic-ketoacidosis-market